Exp Clin Endocrinol Diabetes 1998; 106(4): 310-318
DOI: 10.1055/s-0029-1211991
Original

© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Regulation of the HGF-receptor c-met in the thyroid gland

K. M. Schulte, G. Antoch, M. Ellrichmann, M. Finken-Eigen* , K. Köhrer* , D. Simon, P. E. Goretzki, H. D. Röher
  • Dept. for General and Trauma Surgery, Heinrich Heine University, Düsseldorf, Germany
  • * Center for Biological and Medical Research, Heinrich Heine University, Düsseldorf, Germany
Further Information

Publication History

Publication Date:
14 July 2009 (online)

Summary

HGF (hepatocyte growth factor) has been characterised as an important mitogen and motogen in many epithelial cells. The biological and clinical significance of HGF and its receptor c-met in the thyroid is currently under study. Overexpression of c-met is an important feature of papillary thyroid cancer. We developed a quantitative differential RT-PCR method in order to examine HGF-receptor regulation using RNA of about 50 cells per analysis. Experiments were performed in three spontaneously transformed follicular thyroid cancer (FTC) cell lines FTC-I 33, 236, and 238, 7 primary cultures derived from multinodular goitres, one from Graves disease and 1 from papillary thyroid cancer (PTC). TGF. alpha and to a minor degree HGF were shown to induce a marked up-regulation of the receptor whereas bovine TSH, NaT, dbcAMP or basic FGF had no apparent effect. We conclude that expression of the HGF-receptor is under control of paracrine growth factors activating tyrosine-kinase-dependent pathways. We could demonstrate a minor stimulation of thyroid cell proliferation by HGF in presence but not in absence of l0% fetal calf serum.